TUCSON, AZ / ACCESS Newswire / February 19, 2026 / Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building ...
About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, ...
In sum, the nonapeptide Oxytocin presents as a structurally well-defined peptide with a receptor system that is widely ...
Innate immune sensors – known as pattern recognition receptors (PRRs) – detect specific molecular components of bacterial or ...
Researchers have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a new study. The findings hold ...
GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.
P2Y receptors constitute a distinct subfamily of G protein-coupled receptors (GPCRs) that are activated by extracellular nucleotides, such as ATP, ADP, UTP, UDP and various nucleotide sugars. These ...
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...
Morning Overview on MSN
Scientists find 'molecular switch' that supercharges natural immunity
A team led by researchers at the University of Cologne has identified a protein called ANKIB1 that acts as a volume dial for the body’s frontline immune defenses, controlling how strongly cells ...
News-Medical.Net on MSN
NIH grant supports research on immune-related receptor in neurons
Florida Atlantic University has received a $2.4 million grant from the National Institutes of Health to investigate how an immune-related receptor in neurons plays a fundamental role in brain function ...
Nerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Researchers at the NYU Pain Research Center have found a new receptor for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results